Related Experiment Video
Updated: Mar 13, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer
Alexis Hugentobler1, Laurent Gilbeau, Jean-Noel Talbot
1From the *Hôpital Privé de la Louvière, Médecine Nucléaire, Lille; †Centre Gray, Radiothérapie, Route d'Assevent, Maubeuge; and ‡Hôpital Tenon-APHP, Médecine Nucléaire, Paris, France.
Abstract:
Breast cancer is approximately 100 times less common among men. Estrogen-related receptor α was detected in human prostate cancer tissue, and androgen receptors are expressed in both normal and malignant breast tissue. Thus, prostate cancer hormonal therapy may increase breast cancer risk. A 67-year-old man with prostate cancer history presented with rising prostate-specific antigen level. F-Fluorocholine PET/CT showed intense uptake in his right breast and moderate uptake in right axillary lymph node. Complementary F-FDG PET/CT demonstrated more intense tracer uptakes in both the right breast and axillary lymph node. Breast histological findings were invasive ductal cancer, with axillary lymph node invasion.
